These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12029432)

  • 41. [Therapy of primary brain tumors with segidrin].
    Filov VA; Gershanovich ML; Ivin BA; Danova LA; Gurchin FA; Naryshkin AG; Leshchinskiĭ VI; Zemskaia AG; Nikiforov BM; Breĭvis PV
    Vopr Onkol; 1994; 40(7-12):332-6. PubMed ID: 7610631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ultra-high, short-term dexamethasone therapy in craniocerebral trauma. Rationale and design of a multicenter study].
    Gaab MR; Dietz H
    Neurochirurgia (Stuttg); 1989 Jul; 32(4):93-100. PubMed ID: 2671769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment results in severe craniocerebral trauma with and without dexamethasone therapy].
    Sollmann WP; Hussein S; Stolke D
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):46-50. PubMed ID: 3990889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical, chemical, and CT evaluation of short-term and long-term antiedema therapy with dexamethasone and diuretics.
    Meinig G; Reulen HJ; Simon RS; Schürmann K
    Adv Neurol; 1980; 28():471-89. PubMed ID: 7457258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain metastases.
    Kamar FG; Posner JB
    Semin Neurol; 2010 Jul; 30(3):217-35. PubMed ID: 20577929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use and toxicity of steroids in the management of patients with brain metastases.
    Sturdza A; Millar BA; Bana N; Laperriere N; Pond G; Wong RK; Bezjak A
    Support Care Cancer; 2008 Sep; 16(9):1041-8. PubMed ID: 18256860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.
    Panickar KS
    Curr Opin Mol Ther; 2010 Dec; 12(6):780-9. PubMed ID: 21154169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycerol: a successful alternative to dexamethasone for patients receiving brain irradiation for metastatic disease.
    Bedikian AY; Valdivieso M; Heilbrun LK; Withers RH; Benjamin RS; Gutterman JU; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1978 Jul; 62(7):1081-3. PubMed ID: 688248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain irradiation and antioedematous dexamethasone treatment--risk factors for herpes simplex encephalitis?
    Dragoje S; Tolnay M; Dalquen P; Probst A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(6):277-80. PubMed ID: 8867358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain metastases and steroid reduction after radiotherapy.
    Thomson AH; Tomlinson MJ
    Palliat Med; 2004 Oct; 18(7):665-6. PubMed ID: 15540679
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experiences with dexamethasone in the therapy of brain edema in the preoperative phase].
    Waldmann KD; Demmler M
    Psychiatr Neurol Med Psychol (Leipz); 1987 Feb; 39(2):115-20. PubMed ID: 3588761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases.
    Weissman DE; Janjan NA; Erickson B; Wilson FJ; Greenberg M; Ritch PS; Anderson T; Hansen RM; Chitambar CR; Lawton CA
    J Neurooncol; 1991 Dec; 11(3):235-9. PubMed ID: 1726656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma.
    Dubinski D; Won SY; Gessler F; Quick-Weller J; Behmanesh B; Bernatz S; Forster MT; Franz K; Plate KH; Seifert V; Harter PN; Senft C
    J Neurooncol; 2018 May; 137(3):503-510. PubMed ID: 29349612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.
    Vecht CJ; Hovestadt A; Verbiest HB; van Vliet JJ; van Putten WL
    Neurology; 1994 Apr; 44(4):675-80. PubMed ID: 8164824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cutaneous paresthesia in high-dose intravenous dexamethasone therapy in oncology].
    Rasche H; Meier CR; Schneider J; Gröticke J; Schönhöfer P
    Dtsch Med Wochenschr; 1986 Sep; 111(37):1406-7. PubMed ID: 2943576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical Practice.
    Palombi L; Marchetti P; Salvati M; Osti MF; Frati L; Frati A
    Anticancer Res; 2018 Apr; 38(4):2423-2427. PubMed ID: 29599372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective survey of the use of dexamethasone on a palliative care unit.
    Hardy JR; Rees E; Ling J; Burman R; Feuer D; Broadley K; Stone P
    Palliat Med; 2001 Jan; 15(1):3-8. PubMed ID: 11212465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema.
    Ikeda Y; Carson BS; Lauer JA; Long DM
    J Neurosurg; 1993 Nov; 79(5):716-21. PubMed ID: 8410250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treating primary brain tumours with dexamethasone.
    McNamara S; Kilbride L
    Nurs Times; 1999 Nov 24-Dec 1; 95(47):54-7. PubMed ID: 11096908
    [No Abstract]   [Full Text] [Related]  

  • 60. Steroids in neurooncology: actions, indications, side-effects.
    Roth P; Wick W; Weller M
    Curr Opin Neurol; 2010 Dec; 23(6):597-602. PubMed ID: 20962642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.